Glucosamine Improved Atopic Dermatitis-like Skin Lesions in NC/Nga Mice by Inhibition of Th2 Cell Development

Scandinavian Journal of Immunology

Volumn 73, Issue 6, 2011, Pages 536-545

  Kim, C H ^a   Cheong, K A ^b   Park, C D ^c   Lee, A Y ^b  

^a Dongguk University   (South Korea)

^b Dongguk University College of Medicine   (South Korea)

^c Research Institute of Hurim Biocell   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSAMINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATOPIC DERMATITIS; CONTROLLED STUDY; DRUG EFFECT; HISTOLOGY; MALE; MOUSE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; SCORING SYSTEM; TH2 CELL; TREATMENT OUTCOME;

ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; CELL DIFFERENTIATION; CYTOKINES; DERMATITIS, ATOPIC; GATA3 TRANSCRIPTION FACTOR; GLUCOSAMINE; HISTOCYTOCHEMISTRY; IMMUNOGLOBULIN E; IMMUNOSUPPRESSIVE AGENTS; MALE; MICE; PYROGLYPHIDAE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; T-BOX DOMAIN PROTEINS; TH2 CELLS;

EID: 79955377427     PISSN: 03009475     EISSN: 13653083     Source Type: Journal    
DOI: 10.1111/j.1365-3083.2011.02526.x     Document Type: Article

References (40)

1. Hoare C, Li Wan Po A, Williams H. Systematic review of treatments for atopic eczema. Health Technol Assess 2000;4:1-191.
2. Leung DY, Bieber T. Atopic dermatitis. Lancet 2003;361:151-60.
3. Cookson W. The immunogenetics of asthma and eczema: a new focus on the epithelium. Nat Rev Immunol 2004;4:978-88.
4. Leung DY, Boguniewicz M, Howell MD, Nomura I, Hamid QA. New insights into atopic dermatitis. J Clin Invest 2004;113:651-7.
5. Spergel JM, Mizoguchi E, Oettgen H, Bhan AK, Geha RS. Roles of TH1 and TH2 cytokines in a murine model of allergic dermatitis. J Clin Invest 1999;103:1103-11.
6. Grewe M, Bruijnzeel-Koomen CA, Schöpf E et al. A role for Th1 and Th2 cells in the immunopathogenesis of atopic dermatitis. Immunol Today 1998;19:359-61.
7. Murai M, Yoneyama H, Harada A et al. Overproduction of Th2-specific chemokines in NC/Nga mice exhibiting atopic dermatitis-like lesions. J Clin Invest 1999;104:1097-105.
8. Miraglia del Giudice M, Decimo F, Leonardi S et al. Immune dysregulation in atopic dermatitis. Allergy Asthma Proc 2006;27:451-5.
9. Wan YY, Flavell RA. How diverse - CD4 effector T cells and their functions. J Mol Cell Biol 2009;1:20-36.
10. Zhu J. Transcriptional regulation of Th2 cell differentiation. Immunol Cell Biol 2010;88:244-9.
11. Das J, Chen CH, Yang L, Cohn L, Ray P, Ray A. A critical role for NF-kappa B in GATA3 expression and TH2 differentiation in allergic airway inflammation. Nat Immunol 2001;2:45-50.
12. Mullen AC, High FA, Hutchins AS et al. Role of T-bet in commitment of TH1 cells before IL-12-dependent selection. Science 2001;292:1907-10.
13. Pai SY, Truitt ML, Ho IC. GATA-3 deficiency abrogates the development and maintenance of T helper type 2 cells. Proc Natl Acad Sci U S A 2004;101:1993-8.
14. Yamashita M, Ukai-Tadenuma M, Miyamoto T et al. Essential role of GATA3 for the maintenance of type 2 helper T (Th2) cytokine production and chromatin remodeling at the Th2 cytokine gene loci. J Biol Chem 2004;279:26983-90.
15. Maneechotesuwan K, Xin Y, Ito K et al. Regulation of Th2 cytokine genes by p38 MAPK-mediated phosphorylation of GATA-3. J Immunol 2007;178:2491-8.
16. Towheed TE, Anastassiades T. Glucosamine therapy for osteoarthritis: an update. J Rheumatol 2007;34:1787-90.
17. Forchhammer L, Thorn M, Met O, Gad M, Weidner MS, Claesson MH. Immunobiological effects of glucosamine in vitro. Scand J Immunol 2003;58:404-11.
18. Ma L, Rudert WA, Harnaha J et al. Immunosuppressive effects of glucosamine. J Biol Chem 2002;277:39343-9.
19. Matsuda H, Watanabe N, Geba GP et al. Development of atopic dermatitis-like skin lesion with IgE hyperproduction in NC/Nga mice. Int Immunol 1997;9:461-6.
20. Suto H, Matsuda H, Mitsuishi K et al. NC/Nga mice: a mouse model for atopic dermatitis. Int Arch Allergy Immunol 1999;120:70-5.
21. Vestergaard C, Yoneyama H, Matsushima K. The NC/Nga mouse: a model for atopic dermatitis. Mol Med Today 2000;6:209-10.
22. Jin H, He R, Oyoshi M, Geha RS. Animal models of atopic dermatitis. J Invest Dermatol 2009;129:31-40.
23. Sanda T, Yasue T, Oohashi M, Yasue A. Effectiveness of house dust-mite allergen avoidance through clean room therapy in patients with atopic dermatitis. J Allergy Clin Immunol 1992;89:653-7.
24. Katoh N, Hirano S, Suehiro M, Masuda K, Kishimoto S. The characteristics of patients with atopic dermatitis demonstrating a positive reaction in a scratch test after 48hours against house dust mite antigen. J Dermatol 2004;31:720-6.
25. Matsuoka H, Meada N, Atsuta Y, Ando K, Chinzei Y. Seasonal fluctuations of Dermatophagoides mite population in house dust. Jpn J Med Sci Biol 1995;48:103-15.
26. Yamamoto M, Haruna T, Yasui K et al. A novel atopic dermatitis model induced by topical application with dermatophagoides farinae extract in NC/Nga mice. Allergol Int 2007;56:139-48.
27. Ohga K, Kuromitsu S, Takezawa R et al. YM-341619 suppresses the differentiation of spleen T cells into Th2 cells in vitro, eosinophilia, and airway hyperresponsiveness in rat allergic models. Eur J Pharmacol 2008;590:409-16.
28. Vercelli D, Geha RS. Regulation of isotype switching. Curr Opin Immunol 1992;4:794-7.
29. Galli SJ, Nakae S, Tsai M. Mast cells in the development of adaptive immune responses. Nat Immunol 2005;6:135-42.
30. Caron G, Delneste Y, Roelandts E et al. Histamine polarizes human dendritic cells into Th2 cell-promoting effector dendritic cells. J Immunol 2001;167:3682-6.
31. Gosset P, Bureau F, Angeli V et al. Prostaglandin D2 affects the maturation of human monocyte-derived dendritic cells: consequence on the polarization of naive Th cells. J Immunol 2003;170:4943-52.
32. Murphy KM, Reiner SL. The lineage decisions of helper T cells. Nat Rev Immunol 2002;2:933-44.
33. Ho IC, Glimcher LH. Transcription: tantalizing times for T cells. Cell 2002;109 (Suppl):S109-20.
34. Ouyang W, Ranganath SH, Weindel K et al. Inhibition of Th1 development mediated by GATA-3 through an IL-4-independent mechanism. Immunity 1998;9:745-55.
35. Ho IC, Hodge MR, Rooney JW, Glimcher LH. The proto-oncogene c-maf is responsible for tissue-specific expression of interleukin-4. Cell 1996;85:973-83.
36. Ouyang W, Jacobson NG, Bhattacharya D et al. The Ets transcription factor ERM is Th1-specific and induced by IL-12 through a Stat4-dependent pathway. Proc Natl Acad Sci U S A 1999;96:3888-93.
37. Sica A, Dorman L, Viggiano V et al. Interaction of NF-kappaB and NFAT with the interferon-gamma promoter. J Biol Chem 1997;272 (48):30412-20.
38. Rafi MM, Yadav PN, Rossi AO. Glucosamine inhibits LPS-induced COX-2 and iNOS expression in mouse macrophage cells (RAW 264.7) by inhibition of p38-MAP kinase and transcription factor NF-kappaB. Mol Nutr Food Res 2007;51:587-93.
39. Wakugawa M, Nakamura K, Kakinuma T, Onai N, Matsushima K, Tamaki K. CC chemokine receptor 4 expression on peripheral blood CD4+ T cells reflects disease activity of atopic dermatitis. J Invest Dermatol 2001;117:188-96.
40. Jujo K, Renz H, Abe J, Gelfand EW, Leung DY. Decreased interferon gamma and increased interleukin-4 production in atopic dermatitis promotes IgE synthesis. J Allergy Clin Immunol 1992;90:323-31.